The effects of four intravenous combinations, xylazine (0.7 mg/kg)/methadone (0.1 mg/kg), xylazine (0.7 mg/kg)/buprenorphine (0.004 and 0.006 mg/kg) and acepromazine (0.05 mg/kg)/buprenorphine (0.006 mg/kg) on arterial blood pressure, central venous pressure, heart rate, respiratory rate and blood gases were studied in four experimental ponies. With xylazine/buprenorphine and xylazine/methadone onset of sedation was rapid and obvious and although no surgical or diagnostic procedures were carried out, sedation was judged to be satisfactory for the next 30 to 40 minutes. Onset of sedation after intravenous injection of acepromazine/buprenorphine was slower and less obvious, while its duration was difficult to determine for the ponies could be aroused by noise even when apparently fully sedated. The observations indicated that at the stated doses all the drug combinations should be safe for clinical use.
Central venous pressure measurements were made in 74 horses and ponies free from clinical evidence of cardiopulmonary disease. Using the sternal manubrium as the zero reference point, the mean value obtained was 12 cm H2O (S.D. +/- 6). There was a significant correlation with body weight (r=0.6, p less than 0.001) but there was none with age, sex, breed or type. During halothane anaesthesia, using the same reference point, the mean value was 24.5 cm H2O (S.D. +/- 6) in 28 animals in right lateral recumbency, 29 cm H2O (S.D. +/- 8) in 17 animals in left lateral recumbency and -6 cm H20 (S.D. +/- 4) IN 27 supine animals. The use of the sternal manubrium as zero reference point did not allow comparison of values in standing and recumbent animals and it was considered that serial measurements were of more value than isolated determinations in assessing the circulatory state of an animal.
The effects of combining large doses of xylazine (1.1 mg per kg intravenously) with ketamine, methohexitone and thiopentone were studied in four experimental ponies. Onset of anaesthesia was more delayed after ketamine than after the barbiturates. Assessment of smoothness of induction and recovery indicated that all three combinations were effective and acceptable. Injection of xylazine was followed by atrioventricular (A-V) block which could be prevented by the prior administration of atropine. Blood pressure was well maintained with all three combinations of drugs. Arterial oxygen tension decreased as soon as the ponies became recumbent but there were no marked changes in arterial blood pH or carbon dioxide tension. Cardiac output was measured in one pony and was found to be least affected by ketamine. There was no great difference between the recumbency times after ketamine and methohexitone but thiopentone produced a significantly longer period of recumbency. In every instance the animals stood at the first attempt without struggling or excitement. The ability of the three drug combinations to produce surgically useful anaesthesia was not tested.
The pressure flow characteristics of a demand valve which has been suggested to be suitable for use in anaesthetised horses were determined at a range of flow rates commonly encountered in equine anaesthesia. The resistance of the valve was found to be very much greater than the resistance of normal large animal anaesthetic apparatus or the equine lower respiratory tract. The effects of the valve on pulmonary ventilation were investigated in seven anaesthetised, intubated horses. Respiratory rate and dynamic compliance were unaffected by connection of the valve but mean tidal and minute volumes and peak flow rates were substantially reduced. The change in transpulmonary pressure over the respiratory cycle was doubled and indices of work of breathing increased by a factor of three. It was concluded that the resistance offered by the valve was too great for its use in spontaneously breathing horses to be recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.